Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Puretech Health PLC
Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune

PureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune.

It operates through the following segments: Growth Stage Businesses; Project Phase Businesses; and Parent Company and Others.

The Growth Stage Businesses segment focuses on the development on products to solve major healthcare problems in varied markets.

The Project Phase Businesses segment covers the financing, sourcing, and creating new product candidates as well as newly created businesses whose technologies are in the process of validation.

The Parent Company and Others segment involves commences initiatives in themes; raises capital for investment in new companies and existing subsidiaries; and provides other corporate shared services and support for all subsidiaries as well as manages the new company creation process.

The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

Number of employees : 95 persons.
Sales per Businesses
20152016Delta
GBP (in Million)%GBP (in Million)%
Growth Stage Programmes6.6786.2%3.0592.9% -54.28%
Project Phase Programmes1.0713.9%0.2487.5% -76.9%
Sales per Regions
20152016Delta
GBP (in Million)%GBP (in Million)%
United States7.6999.3%3.2398.5% -57.92%
Outside United States0.0580.8%0.0641.9% +9.85%
Managers
NameAgeSinceTitle
Daphne Zohar-2015Chief Executive Officer & Executive Director
Bharatt M. Chowrira, PhD512017President, Chief Business & Strategy Officer
Joichi Ito51-Non-Executive Chairman
Stephen Muniz--Chief Operations Officer, Secretary & Director
Eric Elenko, PhD--Chief-Research & Strategy
Joseph B. Bolen, PhD632016Chief Scientific Officer
Atul C. Pande, MD622017Chief Medical Officer
Dame Marjorie Morris Scardino702015Senior Independent Non-Executive Director
Bennett M. Shapiro, MD772015Non-Executive Director
Robert S. Langer Jr., DSc672015Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 237,429,696 182,773,872 77.0% 0 0.0% 77.0%
Shareholders
NameEquities%
Invesco Asset Management Ltd. 75,964,145 32.0%
Lansdowne Partners (UK) LLP 21,364,916 9.00%
Baillie Gifford & Co. 11,869,398 5.00%
Jupiter Asset Management Ltd. 11,861,309 5.00%
Recordati SpA 9,554,140 4.02%
Daphne Zohar 7,134,094 3.00%
Aviva Investors Global Services Ltd. 3,538,000 1.49%
Ruffer LLP 3,500,000 1.47%
Robert S. Langer Jr., DSc 2,939,834 1.24%
David Steinberg, MBA 2,825,000 1.19%
Company contact information
PureTech Health Plc
501 Boylston Street
Suite 6102
Boston, MA 02116

Phone : +1.617.482.2333
Fax : +1.617.482.3337
Web : www.puretechhealth.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PURETECH HEALTH PLC5.09%388
CELLTRION, INC.--.--%24 558
INCYTE CORPORATION5.19%22 258
IQVIA HOLDINGS INC37.36%22 074
LONZA GROUP59.15%19 560
ALNYLAM PHARMACEUTICALS, INC.240.57%12 538
SEATTLE GENETICS, INC.13.30%8 605
ALKERMES PLC-12.92%7 443
QIAGEN NV6.61%7 160
NEKTAR THERAPEUTICS266.67%7 084
EXACT SCIENCES CORPORATION340.64%7 049
IONIS PHARMACEUTICALS INC13.21%6 734
ICON PLC55.92%6 336
UNITED THERAPEUTICS CORPORATION-14.23%5 316
PRA HEALTH SCIENCES INC46.41%5 114
BIO-TECHNE CORP25.66%4 841
CHARLES RIVER LABORATORIES INTL. INC33.08%4 802
GALAPAGOS26.90%4 637
PUMA BIOTECHNOLOGY INC243.65%3 959
INC RESEARCH HOLDINGS INC-28.23%3 939
FIBROGEN INC119.04%3 844
Connections : Puretech Health PLC
Akili Interactive Labs, Inc.
American Academy of Arts & Sciences
Knode, Inc.
KensaGroup LLC
The Colorado Bar Association
TARA Biosystems, Inc.
Association of Corporate Counsel
Stembiosys, Inc.
Six Apart KK
The Carter Centre United Kingdom
Helium Systems, Inc.
Dickinson College
480 Biomedical, Inc.
MIT Media Laboratory
Living Proof, Inc.
Culture Convenience Club Co., Ltd.
BI.Garage, Inc.
Royal College of Art
CommenSe, Inc.
The Carter Center, Inc.
The Mozilla Foundation
London School of Hygiene & Tropical Medicine
Silicon Straits Pte Ltd.
Drugs for Neglected Diseases initiative
littleBits Electronics, Inc.
CHS Pharma, Inc.
Oblong Industries, Inc.
Moderna Therapeutics, Inc.
Wearality Corp.
TARIS BioMedical LLC
IperLane, Inc.
Whitehead Institute for Biomedical Research
Thesixtyone, Inc.
Aris Pharmaceuticals, Inc.
Outblaze Ltd.
Massachusetts Institute of Technology
Sanrio, Inc.
Enlight Biosciences LLC
Open Source Initiative
98 Whitehall Court LLP
Blind Spot, Inc.
The Carter Centre UK Foundation
Connected Camps
Bridge International Academies Ltd.
Elephant Design Co. Ltd.
Royal Society of Arts
The Momoko Ito Foundation
Libra Biosciences, Inc.
Neoteny 3 LP
Vedanta Biosciences, Inc.
The Japan Society
The Mind & Life Institute
Wikia Japan
Frequency Therapeutics, Inc.
Technology Review, Inc.
SQZ Biotechnologies Co.
Karuna Pharmaceuticals, Inc.
Tarveda Therapeutics, Inc.
XTuit Pharmaceuticals, Inc.
Gelesis SRL
Seventh Sense Biosystems, Inc.
Gelesis, Inc.
Arsenal Medical, Inc.
Verity BioConsulting LLC
Microchips Biotech, Inc.
Lyndra, Inc.
Micell Technologies, Inc.
The Children's Medical Center Corp.
Humacyte, Inc.
Golub & Co.
Cornell University
Autifony Therapeutics Ltd.
Rubius Therapeutics, Inc.
Roivant Sciences GmbH
Sigilon, Inc.
Noveome Biotherapeutics, Inc.
Gecko Biomedical SAS
David H. Koch Institute for Integrative Cancer Research
Appeering, Inc.
The Water Initiative LLC
Olivo Laboratories LLC
Mandara Sciences LLC
Arsia Therapeutics, Inc.
Victoria & Albert Museum
Suono Bio, Inc.
© 2017 People , Fundamentals and Ownership